Here’s how beagles being bred for research by an Indianapolis-based company became the target of the largest animal welfare seizure in the Humane Society’s history.
Read More
The Grand Park Research & Development Hub will use the 400-acre youth sports campus as a testing ground for new technologies, services and research projects related to facilities and activities in the sports tourism industry.
Read More
Prosecutors said the penalties against Indianapolis-based Envigo RMS, as well as West Lafayette-based parent company Inotiv, amount to the largest ever levied in an animal-welfare case.
Prince Harry and Meghan, Duchess of Sussex, have adopted one of 4,000 beagles that were rescued from abusive conditions at the breeding facility operated by Indianapolis-based Envigo.
A federal judge issued an emergency order late last month imposing a series of restrictions on the facility operated by Indianapolis-based Envigo after regulators said the site was responsible for the deaths of hundreds of beagle puppies.
Repeated federal inspections since Envigo acquired the facility have resulted in dozens of violations, including findings that dogs had received inadequate medical care and insufficient food, were housed in filthy conditions, and some had been euthanized without first receiving anesthesia.
For companies that pursue technological advances and innovative solutions, bias can have an enduring impact, making it easy for the cycle to be perpetuated.
A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.
With a CEO hired and a soon-to-be signed lease for office space, the $360 million Indiana Biosciences Research Institute is ready to lift off.
Covance manages clinical trials for drugmakers including locally-based Eli Lilly and Co. It employs about 1,500 workers in Indianapolis and Greenfield.
The Indiana University School of Medicine plans to hire 100 research professors over the next five years in a bid to vault into the top 25 medical schools.
The company may violate loan covenants in the next three to six months, and its ability to refinance a $280 million loan that matures in July 2014 is “highly questionable,” Moody’s says.
Bioanalytical Systems Inc.’s new CFO won praise this month for laying out an aggressive cost-cutting plan—but not before the rest of the company’s leaders got a tongue lashing for their past performance.
The city of Indianapolis plans to announce a major initiative to turn a stretch of 16th Street northwest of downtown into a hub for biotechnology and other high-tech companies.
The Metropolitan Development Commission on Wednesday preliminarily approved Advion BioServices Inc.’s request for a tax abatement to build a laboratory at Purdue Research Park in Indianapolis.
The government's allegations read like a spy novel: Dr. Ke-xue "John" Huang lands a job at Indianapolis-based Dow AgroSciences and over five years works himself into a position of trust, with access to trade secrets and processes the company has invested $300 million to develop.
A federal indictment unsealed Tuesday in Indianapolis charged 45-year-old Ke-xue "John" Huang
with theft and attempted
theft of trade secrets to benefit a foreign government.
The U.S. Department of Justice has charged Ke-xue Huang, a native of China’s Hunan province, of stealing trade secrets of
a Dow AgroSciences insecticide and giving them to the People’s Republic of China. Federal agents arrested the former Dow Agro
scientist July 13 in Westboro, Mass.
Bioanalytical Systems Inc. narrowed its losses in the second fiscal quarter despite a 2 percent drop in revenue, the West
Lafayette-based contract research firm said late last week.
West Lafayette-based Bioanalytical Systems Inc. has promoted Anthony S. Chilton to CEO following the retirement of top executive
Richard M. Shepperd earlier this year.
The firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
A report set to be released Wednesday by local life sciences industry group BioCrossroads says Indiana companies providing
contract pharmaceutical research and manufacturing services are weathering the economic downturn and are growing.
